Related Experiment Video
Updated: Feb 8, 2026

08:03
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
9.5K
Recent advances in nanoparticle carriers for photodynamic therapy
Gawon Yi1, Suk Ho Hong2, Jihwan Son1
1Department of Medical Lifescience, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Quantitative Imaging in Medicine and Surgery
|June 22, 2018
Summary
Recent advances in nanoparticle (NP) development enhance photodynamic therapy (PDT) efficiency. Nanoparticle carriers improve photosensitizer delivery and stability for targeted disease treatment.
Area of Science:
- Biomedical Engineering
- Materials Science
- Oncology
Background:
- Photodynamic therapy (PDT) requires efficient delivery of photosensitizers (PSs) to target sites.
- Nanoparticles (NPs) offer a promising platform for drug delivery and medical imaging.
- Nanomedicine approaches are crucial for overcoming challenges in PDT efficacy.
Purpose of the Study:
- To review recent advancements in NP-based strategies for enhanced photodynamic therapy.
- To explore the application of organic and inorganic NPs as carriers for photosensitizers.
- To highlight novel PDT techniques and the role of NPs in their development.
Main Methods:
- Literature search of the PubMed database using keywords: NP, nanomedicine, PDT, photosensitizer (PSs), and drug delivery.
- Analysis of studies focusing on NP carriers for PSs in PDT applications.
- Review of emerging PDT techniques like aggregation-induced emission (AIE) and luminescence-based PDT.
Main Results:
- NP carriers significantly improve the water solubility and stability of PSs for in vivo administration.
- NP delivery systems enhance PS circulation time and accumulation at target disease sites.
- Various NP formulations, based on organic and inorganic materials, have demonstrated efficacy in PDT.
Conclusions:
- Nanoparticles are pivotal in advancing photodynamic therapy by improving photosensitizer delivery and therapeutic outcomes.
- Nanomedicine strategies utilizing NPs are essential for developing more effective and targeted PDT treatments.
- This review provides valuable insights for researchers developing or applying NPs in efficient PDT.
Related Concept Videos
Electron Carriers
92.0K
Electron carriers can be thought of as electron shuttles. These compounds can easily accept electrons (i.e., be reduced) or lose them (i.e., be oxidized). They play an essential role in energy production because cellular respiration is contingent on the flow of electrons.
Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
92.0K
Carrier Transport
972
The generation of electrical current in semiconductors is fundamentally driven by two mechanisms: drift and diffusion. These processes are essential for the functionality and performance of semiconductor-based devices.
Drift Current:
The drift of charge carriers is started by an external electric field (E). Charged particles, such as electrons and holes, experience an acceleration between collisions with lattice atoms. For electrons, this results in a drift velocity (vd) given by:
Drift Current:
The drift of charge carriers is started by an external electric field (E). Charged particles, such as electrons and holes, experience an acceleration between collisions with lattice atoms. For electrons, this results in a drift velocity (vd) given by:
972
The ADP/ATP Carrier Protein
4.3K
ADP/ATP carrier or AAC protein is the most abundant carrier protein in the inner mitochondrial membrane. It transports large quantities of ADP and ATP, equivalent to the average human body weight, every day. Among other transporters, ACC protein is one of the best-studied members of the mitochondrial carrier protein family. The ADP/ATP carrier protein comprises two transmembrane helices connected to a loop and a single alpha-helix on the matrix side. It switches between two conformational...
4.3K
Carrier Generation and Recombination
1.3K
Carrier generation is the process by which electron-hole pairs (EHPs) are created within the semiconductor. In direct-bandgap semiconductors, such as gallium arsenide (GaAs), this occurs efficiently when energy absorption prompts valence electrons to leap into the conduction band, leaving behind holes.
This process is given by the generation rate G and is efficient due to the conservation of momentum between the valence band maximum and conduction band minimum.
Indirect generation involves an...
This process is given by the generation rate G and is efficient due to the conservation of momentum between the valence band maximum and conduction band minimum.
Indirect generation involves an...
1.3K
Carrier-Mediated Transport
1.3K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.3K
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K

